title: [Regulation and control of wenshen yangxue granule combined with clomifene citrate on INH-ACT-FS system in patients with follicular maldevelopment infertility].
abstract: OBJECTIVE
  To observe the clinical curative effect of Wenshen Yangxue Granule (WSYXG) combined with clomifene citrate (CC) in treating follicular maldevelopment (FM) infertility, and to explore its possible action channels.
  
  
  METHODS
  Ninety patients with FM of Shen-deficiency blood stasis syndrome were randomly assigned to 3 groups, i.e., the Chinese medicine group (CMG, treated with WXYXG), the Western medicine group (WMG, treated with CC), and the combination group of Chinese medicine and Western medicine (CG, treated with both WSYXG and CC), 30 cases in each group. Three menstrual cycles were totally observed. Serum levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2 ), inhibin B (INHB), activin A (ACTA), and follistatin (FS) were tested before and after treatment, and the ovulation was monitored and their basic body temperature measured.
  
  
  RESULTS
  There was no statistical difference in clinical efficacy among the three groups (P> 0.05). Better effects on the Chinese medicine syndrome efficacy, the ovulation rate, and the endometrium thickness on the ovulation day were shown in CMG and CG than in WMG, showing statistical difference (P < 0.05). The E2 level increased on the third day of the first menstrual cycle in CG when compared with before treatment. On the 10th day of the 1st menstrual cycle, the INHB and FS increased and the ACTA decreased, showing statistical difference (P < 0.05). On the 10th day of the 3rd menstrual cycle the serum LH level decreased more obviously in CG than in WMG, showing statistical difference (P < 0.05). On the 3rd day of the 3rd menstrual cycle in CG, the INHB was negatively correlated with FSH (r = -0.492,P < 0.01), and INHB on the 10th day was positively correlated with E2 and FS (r = 0.682, 0.772, P < 0.01), and negatively correlated with ACTA on the 10th day (r = -0.635, P < 0.01).
  
  
  CONCLUSIONS
  WSYXG combined with CC could improve Chinese medicine syndrome, regulate the expressions of FM patients' ovary local factors INHB, ACTA and FS, improve the condition of ovary functions, and control the follicle development.
authors.affiliation: Department of Traditional Chinese Medicine, Beijing Hospital of Obstetrics and Gynecology, Capital Medical University, Beijing. xinmingwei@126.com
authors.forename: Xin
authors.initials: X
authors.lastname: Ming-wei
authors.forename: Liang
authors.initials: L
authors.lastname: Xin-yun
authors.forename: He
authors.initials: H
authors.lastname: Jun-qin
mesh_terms: D028341:Activins / Q000097:blood; D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D038681:Follistatin / Q000097:blood; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D007265:Inhibins / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D006080:Ovarian Follicle / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal; D038681:Follistatin; C422405:activin A; C422364:inhibin B; D028341:Activins; D002996:Clomiphene; D007265:Inhibins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone